Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;32(13):e1902005.
doi: 10.1002/adma.201902005. Epub 2019 Sep 9.

Biomaterials for Personalized Cell Therapy

Affiliations
Review

Biomaterials for Personalized Cell Therapy

Amanda L Facklam et al. Adv Mater. 2020 Apr.

Abstract

Cell therapy has already had an important impact on healthcare and provided new treatments for previously intractable diseases. Notable examples include mesenchymal stem cells for tissue regeneration, islet transplantation for diabetes treatment, and T cell delivery for cancer immunotherapy. Biomaterials have the potential to extend the therapeutic impact of cell therapies by serving as carriers that provide 3D organization and support cell viability and function. With the growing emphasis on personalized medicine, cell therapies hold great potential for their ability to sense and respond to the biology of an individual patient. These therapies can be further personalized through the use of patient-specific cells or with precision biomaterials to guide cellular activity in response to the needs of each patient. Here, the role of biomaterials for applications in tissue regeneration, therapeutic protein delivery, and cancer immunotherapy is reviewed, with a focus on progress in engineering material properties and functionalities for personalized cell therapies.

Keywords: biomaterials; cell therapy; drug delivery; immunotherapy; personalized medicine; regenerative medicine.

PubMed Disclaimer

References

    1. T. R. J. Heathman, A. W. Nienow, M. J. Mccall, K. Coopman, B. Kara, C. J. Hewitt, Regener. Med. 2015, 10, 49.
    1. a) N. Mitrousis, A. Fokina, M. S. Shoichet, Nat. Rev. Mater. 2018, 3, 441;
    1. b) C. M. Madl, S. C. Heilshorn, H. M. Blau, Nature 2018, 557, 335.
    1. a) G. Basta, P. Montanucci, G. Luca, C. Boselli, G. Noya, B. Barbaro, M. Qi, K. P. Kinzer, J. Oberholzer, R. Calafiore, Diabetes Care 2011, 34, 2406;
    1. b) D. Jacobs-Tulleneers-Thevissen, M. Chintinne, Z. Ling, P. Gillard, L. Schoonjans, G. Delvaux, B. L. Strand, F. Gorus, B. Keymeulen, D. Pipeleers, Diabetologia 2013, 56, 1605.

MeSH terms

Substances

LinkOut - more resources